Zeenat Jaisani

Zeenat Jaisani practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Zeenat Jaisani's NPI, 1215223938, was assigned on June 21, 2011. Zeenat Jaisani holds Alabama license 35212.

Zeenat Jaisani's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

Zeenat Jaisani's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Zeenat Jaisani is also affiliated with UAB Hospital. The medical group on file is UAB Medicine.

Dmand AI tracks the electronic health record (EHR) system at each site where Zeenat Jaisani practices. Vendor and product names are available with a free account.

Neurology is Zeenat Jaisani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Zeenat Jaisani is licensed in Alabama.

CMS data shows 240 Medicare services from Zeenat Jaisani across 6 procedure codes in 2024, for 117 Medicare patients. Medicare paid $21,507 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 117 Medicare patients who saw Zeenat Jaisani in 2024. The largest group is under 65, with 54 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zeenat Jaisani's median patient age at 43, with 63% women.

In 2024, Zeenat Jaisani wrote 1,922 Medicare Part D claims for 151 patients. 78% of them were for generic drugs. CMS names the drug for 1,784 of them, across 31 drugs with 11 or more claims each, at $839,000 in total drug cost. In 2023, CMS named 1,534 claims across 34 drugs.

Zeenat Jaisani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Zeenat Jaisani as offering telehealth.

Dmand AI links 8 papers to Zeenat Jaisani, published from 2013 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Epilepsies, Partial and Brain. Zeenat Jaisani's most frequent co-authors are Andreas V. Alexopoulos, MD, MPH, Imad M. Najm, MD and Kristen O. Riley.

CMS Open Payments shows 18 general payments to Zeenat Jaisani from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Neuropace, Inc. paid the most, $1,782.